CarthroniX is a biopharmaceutical company focused on developing small
molecule-based therapies for degenerative and aging-related diseases, including
arthritis. Our novel technologies are able to preserve, repair and regenerate
cartilage in joints and concurrently suppress inflammation. We are also
developing completely novel solutions for wound healing, skin regeneration and
prevention of tissue fibrosis in the skin and musculoskeletal tissues. Our
discoveries are based on science conducted by world-class researchers at iconic
institutions. We are CarthroniX! We are the future!